Hyperthermia

Leibel and Phillips Textbook of Radiation Oncology, Third Edition

Volumn , Issue , 2010, Pages 1564-1593

  Sneed, Penny K ^a   Stauffer, Paul R ^b   Li, Gloria C ^c   Sun, Xiaorong ^d   Myerson, Robert J ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 82155189375     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5897-7.00076-7     Document Type: Chapter

References (411)

1. W Busch (1866) Uber den einfluss, welchen heftigere erysipelin zuweilig auf organisierte neubildungen ausüben. Verhandlugen des naturhistorischen vereines der preussischen rheinlande und Westphalens 23 28-30.
2. WB Coley (1893) The treatment of malignant tumors by repeated inoculations of erysipelas: with a report of ten original cases. Am J Med Sci 105 486-511.
3. C Müller (1910) Eine neue behandlungsmethode bosartiger geschwulste. Munchener Medizinische Wochenschrift 28 1490-1493.
4. WC Dewey, et al. (1977) Cellular responses to combinations of hyperthermia and radiation. Radiology 123(2), 463-474.
5. WC Dewey, et al. (1980) Cell biology of hyperthermia and radiation. RE Meyn, HR Withers,(Eds) Radiation biology in cancer research New York: Raven Press 589-621.
6. GM Hahn (1982) Hyperthermia and cancer. New York: Plenum Press
7. J Overgaard (1989) The current and potential role of hyperthermia in radiotherapy. Int J Radiat Oncol Biol Phys 16(3), 535-549.
8. CA Perez, et al. (1989) Quality assurance problems in clinical hyperthermia and their impact on therapeutic outcome: a report by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 16(3), 551-558.
9. B Emami, et al. (1996) Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors: a prospectively controlled randomized study by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 34(5), 1097-1104.
10. NR Datta, et al. (1990) Head and neck cancers: results of thermoradiotherapy versus radiotherapy. Int J Hyperthermia 6(3), 479-486.
11. J Overgaard, et al. (1995) Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet 345(8949), 540-543.
12. R Valdagni, M Amichetti and G Pani (1988) Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM-UICC) neck nodes: a prospective randomized clinical trial. Int J Radiat Oncol Biol Phys 15(1), 13-24.
13. R Valdagni and M Amichetti (1994) Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys 28(1), 163-169.
14. J Van der Zee, et al. (2000) Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Lancet 355(9210), 1119-1125.
15. CC Vernon, et al. (1996) Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. Int J Radiat Oncol Biol Phys 35(4), 731-744.
16. JR Oleson, et al. (1993) Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment. Int J Radiat Oncol Biol Phys 25(2), 289-297.
17. JBM Jorritsma, et al. (1986) DNA polymerase activity in heat killing and hyperthermia radiosensitization of mammalian cells as observed after fractionated heat treatments. Radiat Res 105(3), 307-319.
18. RI Morimoto, A Tissieres and C Georgopoulos (1994) The biology of heat shock proteins and Molecular Chaperones. Plainview: Cold Spring Harbor Laboratory Press
19. J Landry and N Marceau (1978) Rate limiting events in hyperthermic cell killing. Radiat Res 75(3), 573-585.
20. T Alper (1979) Cellular radiobiology. Cambridge: Cambridge University Press
21. P Privalov (1979) Stability of proteins: small globular proteins. Adv Protein Chem 33 167-241.
22. JR Lepock and J Kruuv (1980) Thermotolerance as a possible cause of the critical temperature at 43° C in mammalian cells. Cancer Res 40(12), 4485-4488.
23. JR Lepock, et al. (1990) Increased thermostability of thermotolerant CHL V79 cells as determined by differential scanning calorimetry. J Cell Physiol 142(3), 628-634.
24. HA Jung (1991) A generalized concept for cell killing by heat. Effect of chronically induced thermotolerance. Radiat Res 127(3), 235-242.
25. GM Hahn and EC Shiu (1986) Adaptation to low pH modifies thermal and thermo-chemical responses of mammalian cells. Int J Hyperthermia 2(4), 379-387.
26. KG Hofer and NF Mivechi (1980) Tumor cell sensitivity to hyperthermia as a function of extracellular and intracellular pH. J Natl Cancer Inst 65(3), 621-625.
27. A Westra and WC Dewey (1971) Variation in sensitivity to heat shock during the cell cycle of Chinese hamster cells in vitro. Int J Radiat Biol 19(5), 467-477.
28. SA Sapareto and WC Dewey (1984) Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 10(6), 787-800.
29. MW Dewhirst and DA Sim (1984) The utility of thermal dose as a predictor of tumor and normal tissue responses to combined radiation and hyperthermia. Cancer Res 44(Suppl 10), 4772s-4780s.
30. M Sherar, et al. (1997) Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a Phase III trial. Int J Radiat Oncol Biol Phys 39(2), 371-380.
31. KA Leopold, et al. (1993) Cumulative minutes with T90 greater than tempindex is predictive of response of superficial malignancies to hyperthermia and radiation. Int J Radiat Oncol Biol Phys 25(5), 841-847.
32. KA Leopold, et al. (1992) Relationships among tumor temperature, treatment time, and histopathological outcome using preoperative hyperthermia with radiation in soft tissue sarcomas. Int J Radiat Oncol Biol Phys 22(5), 989-998.
33. B Rau, et al. (2000) Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: regional radiofrequency hyperthermia correlates with clinical parameters. Int J Radiat Oncol Biol Phys 48(2), 381-391.
34. DS Kapp and RS Cox (1995) Thermal treatment parameters are most predictive of outcome in patients with single tumor nodules per treatment field in recurrent adenocarcinoma of the breast. Int J Radiat Oncol Biol Phys 33(4), 887-899.
35. MJ Borrelli, et al. (1992) Reduction of levels of nuclear-associated protein in heated cells by cycloheximide, D2O, and thermotolerance. Radiat Res 131(2), 204-213.
36. PWJJ Burgman, HH Kampinga and AWT Konings (1993) Possible role of localized protein denaturation in the induction of thermotolerance by heat, sodium-arsenite, and ethanol. Int J Hyperthermia 9(1), 151-162.
37. HH Kampinga, et al. (1995) Thermal protein denaturation and protein aggregation in cells made thermotolerant by various chemicals: role of heat shock proteins. Exp Cell Res 219(2), 536-546.
38. AWT Konings (1988) Membranes are targets for hyperthermic cell killing. Recent Results Cancer Res 109 9-21.
39. A Laszlo (1992) The effects of hyperthermia on mammalian cell structure and function. Cell Prolif 25(2), 59-87.
40. CA Vidair, SJ Doxsey and WC Dewey (1993) Heat shock alters centrosome organization leading to mitotic dysfunction and cell death. J Cell Physiol 154(3), 443-455.
41. WJ Welch and JP Suhan (1985) Morphological study of the mammalian stress response: characterization of changes in cytoplasmic organelles, cytoskeleton, and nucleoli, and appearance of intranuclear actin filaments in rat fibroblasts after heat-shock treatment. J Cell Biol 101(4), 1198-1211.
42. HH Kampinga, et al. (1989) The relationship of increased nuclear protein content induced by hyperthermia to killing of HeLa S3 cells. Radiat Res 117(3), 511-522.
43. JL Roti Roti, KJ Henle and RT Winward (1979) The kinetics of increase in chromatin protein content in heated cells: a possible role in cell killing. Radiat Res 78(3), 522-531.
44. HH Kampinga, et al. (1988) The interaction of heat and radiation affecting the ability of nuclear DNA to undergo supercoiling changes. Radiat Res 116(1), 114-123.
45. Y Hayashi, et al. (1991) Translocation of hsp-70 and protein synthesis during continuous heating at mild temperatures in HeLa cells. Radiat Res 125(1), 80-88.
46. HH Kampinga, et al. (1994) Cells overexpressing hsp27 show accelerated recovery from heat-induced nuclear protein aggregation. Biochem Biophys Res Commun 204(3), 1170-1177.
47. DA Parsell, et al. (1994) Protein disaggregation mediated by heat-shock protein hsp104. Nature 372(6505), 475-478.
48. GJJ Stege, et al. (1994) On the role of hsp72 in heat-induced intranuclear protein aggregation. Int J Hyperthermia 10(5), 659-674.
49. KJ Henle and DB Leeper (1976) Interaction of hyperthermia and radiation in CHO cells: recovery kinetics. Radiat Res 66(3), 505-518.
50. EW Gerner and MJ Schneider (1975) Induced thermal resistance in HeLa cells. Nature 256(5517), 500-502.
51. SB Field and RL Anderson (1982) Thermotolerance: a review of observations and possible mechanisms. Cancer therapy by hyperthermia, drugs and radiation. Natl Cancer Inst Monogr 61 193-201.
52. EW Gerner (1983) Thermotolerance. FK Storm,(Eds) Hyperthermia in cancer therapy Boston: G. K. Hall 141-162.
53. KJ Henle and LA Dethlefsen (1978) Heat fractionation and thermotolerance: a review. Cancer Res 38(7), 1843-1851.
54. SA Sapareto, et al. (1978) Effects of hyperthermia on survival and progression of Chinese hamster ovary cells. Cancer Res 38(2), 393-400.
55. LE Gerweck (1977) Modification of cell lethality at elevated temperatures: the pH effect. Radiat Res 70(1), 224-235.
56. KJ Henle (1987) Thermotolerance in cultured mammalian cells. KJ Henle,(Eds) Thermotolerance Boca Raton: CRC Press 13-71.
57. GM Hahn, et al. (1985) Mechanistic implications of the induction of thermotolerance in Chinese hamster cells by organic solvents. Cancer Res 45(9), 4138-4143.
58. YJ Lee and WC Dewey (1987) Induction of heat shock proteins in Chinese hamster ovary cells and development of thermotolerance by intermediate concentrations of puromycin. J Cell Physiol 132(1), 1-11.
59. GC Li and GM Hahn (1980) A proposed operational model of thermotolerance based on effects of nutrients and the initial treatment temperature. Cancer Res 40(12), 4501-4508.
60. J Lis and C Wu (1993) Protein traffic on the heat shock promoter: parking, stalling, and trucking along. Cell 74(1), 1-4.
61. RI Morimoto, KD Sarge and K Abravaya (1992) Transcriptional regulation of heat shock genes: a paradigm for inducible genomic responses. J Biol Chem 267(31), 21987-21990.
62. RY Liu, et al. (1993) Dual control of heat shock response: involvement of a constitutive heat shock element-binding factor. Proc Natl Acad Sci U S A 90(7), 3078-3082.
63. P Burgman, A Nussenzweig and GC Li (1995) Thermotolerance. MH Seegenschmiedt, P Fessenden, CC Vernon,(Eds) Principles and practice of thermoradiotherapy and thermochemotherapy vol. 1 Berlin, New York: Springer-Verlag 75-87.
64. J Landry, et al. (1989) Heat shock resistance conferred by expression of the human HSP27 gene in rodent cells. J Cell Biol 109(1), 7-15.
65. L. GC Li, et al. (1991) Thermal response of rat fibroblasts stably-transfected with the human 70 kDa heat shock protein-encoding gene. Proc Natl Acad Sci U S A 88(5), 1681-1685.
66. CE Angelidis, I Lazaridis and GN Pagoulatos (1991) Constitutive expression of heat-shock protein 70 in mammalian cells confers thermoresistance. Eur J Biochem 199 35-39.
67. MA Mackey, SL Anolik and JL Roti Roti (1992) Cellular mechanisms associated with the lack of chronic thermotolerance expression in HeLa S3 cells. Cancer Res 52(5), 1101-1106.
68. EP Armour, et al. (1993) Sensitivity of human cells to mild hyperthermia. Cancer Res 53(12), 2740-2744.
69. GP Raaphorst, et al. (1994) Comparison of thermoradiosensitization in two human melanoma cell lines and one fibroblast cell line by concurrent mild hyperthermia and low-dose-rate irradiation. Radiat Res 137(3), 338-345.
70. RI Morimoto, A Tissieres and C Georgopoulos (1990) Stress proteins in biology and medicine. Plainview: Cold Spring Harbor Laboratory Press
71. B Maresca and S Lindquist (1991) Heat shock. New York: Springer-Verlag
72. C Wu, et al. (1990) Transcriptional regulation of heat shock genes. RI Morimoto, A Tissierres, C Georgopoulos,(Eds) Stress proteins in biology and medicine Plainview: Cold Spring Harbor Laboratory Press 429-442.
73. PK Sorger (1991) Heat shock factor and the heat shock response. Cell 65(3), 363-366.
74. JO Hensold, et al. (1990) DNA binding of heat shock factor to the heat shock element is insufficient for transcriptional activation in murine erythroleukemia cells. Mol Cell Biol 10(4), 1600-1608.
75. JJ Gorzowski, et al. (1995) Methylation-associated transcriptional silencing of the major histocompatibility complex-linked hsp70 genes in mouse cell lines. J Biol Chem 270(45), 26940-26949.
76. JL Bruce, et al. (1993) Oxidative injury rapidly activates the heat shock transcription factor but fails to increase levels of heat shock proteins. Cancer Res 53(1), 12-15.
77. RY Liu, PM Corry and YJ Lee (1994) Regulation of chemical stress-induced hsp70 gene expression in murine L929 cells. J Cell Sci 107(Pt 8), 2209-2214.
78. S Leppa, et al. (2001) Differential induction of hsp70-encoding genes in human hematopoietic cells. J Biol Chem 276(34), 31713-31719.
79. SK Mathur, et al. (1994) Deficient induction of human hsp70 heat shock gene transcription in Y79 retinoblastoma cells despite activation of heat shock factor 1. Proc Natl Acad Sci U S A 91(18), 8695-8699.
80. DA Jurivich, et al. (1992) Effect of sodium salicylate on the human heat shock response. Science 255(5049), 1243-1245.
81. D Kim, et al. (1995) A constitutive heat shock element-binding factor is immunologically identical to the Ku-autoantigen. J Biol Chem 270(25), 15277-15284.
82. D Kim, H Ouyang and GC Li (1995) Heat shock protein hsp70 accelerates the recovery of heat-shocked mammalian cells through its modulation of heat shock transcription factor HSF1. Proc Natl Acad Sci U S A 92(6), 2126-2130.
83. RY Liu, PM Corry and YJ Lee (1995) Potential involvement of a constitutive heat shock element binding factor in the regulation of chemical stress-induced hsp70 gene expression. Mol Cell Biochem 144(1), 27-34.
84. GC Li, et al. (1995) Suppression of heat-induced hsp70 expression by the 70-kDa subunit of the human Ku-autoantigen. Proc Natl Acad Sci U S A 92(10), 4512-4516.
85. S-H Yang, et al. (1996) Modulation of thermal induction of hsp70 expression by Ku autoantigen or its individual subunits. Mol Cell Biol 16(7), 3799-3806.
86. D Tang, et al. (2000) Repression of the HSP70B promoter by NFIL6, Ku70, and MAPK involves three complementary mechanisms. Biochem Biophys Res Commun 280 280-285.
87. J Huang, et al. (1997) Heat shock transcription factor 1 binds selectively in vitro to Ku protein and the catalytic subunit of the DNA-dependent protein kinase. J Biol Chem 272(41), 26009-26016.
88. AWT Konings (1995) Interaction of heat and radiation in vitro and in vivo. MH Seegenschmiedt, P Fessenden, CC Vernon,(Eds) Thermoradiotherapy and Thermochemotherapy, vol. 1: Biology, Physiology and Physics Heidelberg: Springer-Verlag 89-102.
89. J Overgaard, OS Nielsen and JC Lindegaard (1987) Biological basis for rational design of clinical treatment with combined hyperthermia and radiation. SB Field, C Franconi,(Eds) Physics and technology of hyperthermia Amsterdam: Martinus Nijhoff 54-79.
90. RL Warters and JL Roti Roti (1982) Hyperthermia and the cell nucleus. Radiat Res 92(3), 458-462.
91. JBM Jorritsma and AWT Konings (1983) Inhibition of repair of radiation-induced strand breaks by hyperthermia and its relation to cell survival after hyperthermia alone. Int J Radiat Biol 43(5), 506-516.
92. HD Mills and RE Meyn (1981) Hyperthermic potentiation of unrejoined DNA strand breaks following irradiation. Radiat Res 87(2), 314-328.
93. E Dikomey and J Franzke (1992) Effect of heat on induction and repair of DNA strand breaks in X-irradiated CHO cells. Int J Radiat Biol 61(2), 221-234.
94. RL Warters and JL Roti Roti (1979) Excision of X-ray-induced thymine damage in chromatin from heated cells. Radiat Res 79(1), 113-121.
95. GJJ Stege, HH Kampinga and AWT Konings (1995) Heat-induced intranuclear protein aggregation and thermal radiosensitization. Int J Radiat Biol 67(2), 203-209.
96. JH Wynstra, WD Wright and JL Roti Roti (1990) Repair of radiation-induced DNA damage in thermotolerant and nonthermotolerant HeLa cells. Radiat Res 124(1), 85-89.
97. HH Kampinga, et al. (1989) Interaction of hyperthermia and radiation in tolerant and nontolerant HeLa S3 cells: role of DNA polymerase inactivation. Int J Radiat Biol 55(3), 423-433.
98. KJ Henle, WA Nagle and AJ Moss (1989) Effect of thermotolerance on the cellular heat-radiation response. M Urano, E Douple,(Eds) Hyperthermia and oncology vol. 2 Boca Raton: VSP 53-81.
99. GP Raaphorst and EI Azzam (1983) Thermal radiosensitization in Chinese hamster (V79) and mouse C3H 10T 1/2 cells. The thermotolerance effect. Br J Cancer 48(1), 45-54.
100. ML Freeman, GP Raaphorst and WC Dewey (1979) The relationship of heat killing and thermoradiosensitization to the duration of heating at 42° C. Radiat Res 78(1), 172-175.
101. AWT Konings (1987) Effects of heat and radiation on mammalian cells. Radiat Phys Chem 30 339-349.
102. DP Heller and GP Raaphorst (1993) Low dose-rate irradiation of human glioma cells and thermoradiosensitization by mild hyperthermia. Radiat Oncol Investig 1 218-226.
103. EP Armour, et al. (1991) Sensitization of rat 9L gliosarcoma cells to low dose rate irradiation by long duration 41° C hyperthermia. Cancer Res 51(12), 3088-3095.
104. E Dikomey (1982) Effect of hyperthermia at 42 and 45° C on repair of radiation-induced DNA strand breaks in CHO cells. Int J Radiat Biol 41(6), 603-614.
105. E Ben Hur and MM Elkind (1974) Thermally enhanced radioresponse of cultured Chinese hamster cells: Damage and repair of single-stranded DNA and a DNA complex. Radiat Res 59(2), 484-495.
106. RL Warters, BW Lyons and J Axtell-Bartlett (1987) Inhibition of repair of radiation-induced DNA damage by thermal shock in Chinese hamster ovary cells. Int J Radiat Biol 51(3), 505-517.
107. O Dahl and O Mella (1990) Hyperthermia and chemotherapeutic agents. SB Field, JW Hand,(Eds) An Introduction to the practical aspects of clinical hyperthermia London, New York: Taylor & Francis 108-142.
108. RK Jain (1997) Barriers to drug delivery in solid tumors. Sci Am 271(1), 58-65.
109. DD Lasic (1993) Liposomes from Physics to Applications. Amsterdam: Elsevier
110. U Massing (1997) Cancer therapy with liposomal formulations of anticancer drugs. Int J Clin Pharmacol Ther 35(2), 87-90.
111. D Campos and C Shapiro (1999) Clinical evaluation of liposomal anthracyclines. A Janoff,(Eds) Liposomes: Rational Design New York: Marcel Dekker, Inc 363-377.
112. A Gabizon and Y Barenholtz (1999) Liposomal anthracyclines. From basics to clinical approval of PEGylated liposomal doxorubicin. A Janoff,(Eds) Liposomes: rational design New York: Marcel Dekker, Inc 343-362.
113. D Needham, et al. (2000) A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res 60(5), 1197-1201.
114. S Ning, et al. (1994) Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy. Int J Radiat Oncol Biol Phys 29(4), 827-834.
115. MB Yatvin, et al. (1978) Design of liposomes for enhanced local release of drugs by hyperthermia. Science 202(4374), 1290-1293.
116. G Kong and MW Dewhirst (1999) Review: hyperthermia and liposomes. Int J Hyperthermia 15(5), 345-370.
117. G Kong, et al. (2000) Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res 60(24), 6950-6957.
118. AM Ponce, et al. (2006) Hyperthermia mediated liposomal drug delivery. Int J Hyperthermia 22(3), 205-213.
119. BL Viglianti, et al. (2004) In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: illustration of targeted delivery. Magn Reson Med 51(6), 1153-1162.
120. Q Chen, et al. (2004) Targeting tumor microvessels using doxorubicin encapsulated in a novel thermosensitive liposome. Mol Cancer Ther 3(10), 1311-1317.
121. AM Ponce, et al. (2007) Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects. J Natl Cancer Inst 99(1), 53-63.
122. PK Srivastava, AB DeLeo and LJ Old (1986) Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc Natl Acad Sci U S A 83(10), 3407-3411.
123. PK Srivastava and RG Maki (1991) Stress-induced proteins in immune response to cancer. Curr Top Microbiol Immunol 167 109-123.
124. PK Srivastava (1993) Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation. Adv Cancer Res 62 153-177.
125. SJ Ullrich, et al. (1986) A mouse tumor-specific transplantation antigen is a heat shock-related protein. Proc Natl Acad Sci U S A 83(10), 3121-3125.
126. H Udono and PK Srivastava (1994) Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. J Immunol 152(11), 5398-5403.
127. Y Tamura, et al. (1997) Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 278(5335), 117-120.
128. S Basu and PK Srivastava (1999) Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity. J Exp Med 189(5), 797-802.
129. PK Srivastava and MR Das (1984) The serologically unique cell surface antigen of Zajdela ascitic hepatoma is also its tumor-associated transplantation antigen. Int J Cancer 33(3), 417-422.
130. S Janetzki, NE Blachere and PK Srivastava (1998) Generation of tumor-specific cytotoxic T lymphocytes and memory T cells by immunization with tumor-derived heat shock protein gp96. J Immunother 21(4), 269-276.
131. J Jimbo, et al. (2008) Induction of leukemia-specific antibodies by immunotherapy with leukemia-cell-derived heat shock protein 70. Cancer Sci 99(7), 1427-1434.
132. X-Y Wang, et al. (2001) Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity. J Immunol 166(1), 490-497.
133. X-Y Wang, et al. (2002) Hsp110 over-expression increases the immunogenicity of the murine CT26 colon tumor. Cancer Immunol Immunother 51(6), 311-319.
134. MH Manjili, et al. (2002) Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110. Cancer Res 62(6), 1737-1742.
135. A Murshid, J Gong and SK Calderwood (2008) Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation. Expert Rev Vaccines 7(7), 1019-1030.
136. A Testori, et al. (2008) Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: The C-100–21 Study Group. J Clin Oncol 26(6), 955-962.
137. B Liu, et al. (2008) A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis. Vaccine 26(10), 1387-1396.
138. EW Gerner, et al. (2000) Heat-inducible vectors for use in gene therapy. Int J Hyperthermia 16(2), 171-181.
139. F Lohr, et al. (2000) Enhancement of radiotherapy by hyperthermia-regulated gene therapy. Int J Radiat Oncol Biol Phys 48(5), 1513-1518.
140. A Vekris, et al. (2000) Control of transgene expression using local hyperthermia in combination with a heat-sensitive promoter. J Gene Med 2(2), 89-96.
141. MJ Borrelli, et al. (2001) Heat-activated transgene expression from adenovirus vectors infected into human prostate cancer cells. Cancer Res 61(3), 1113-1121.
142. Q Huang, et al. (2000) Heat-induced gene expression as a novel targeted cancer gene therapy strategy. Cancer Res 60(13), 3435-3439.
143. GC Li, F He and CC Ling (2006) Hyperthermia and gene therapy: potential use of microPET imaging. Int J Hyperthermia 22(3), 215-221.
144. JJ Parry, et al. (2009) PET imaging of heat-inducible suicide gene expression in mice bearing head and neck squamous cell carcinoma xenografts. Cancer Gene Ther 16(2), 161-170.
145. R Deckers, et al. (2009) Image-guided, noninvasive, spatiotemporal control of gene expression. Proc Natl Acad Sci U S A 106(4), 1175-1180.
146. M Hockel and P Vaupel (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93(4), 266-276.
147. AL Harris (2002) Hypoxia—a key regulatory factor in tumour growth. Nat Rev Cancer 2(1), 38-47.
148. DM Brizel, et al. (1996) Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56(5), 941-943.
149. P Vaupel (2004) Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol 14(3), 198-206.
150. CW Song, H Park and RJ Griffin (2001) Improvement of tumor oxygenation by mild hyperthermia. Radiat Res 155(4), 515-528.
151. A Shakil, JL Osborn and CW Song (1999) Changes in oxygenation status and blood flow in a rat tumor model by mild temperature hyperthermia. Int J Radiat Oncol Biol Phys 43(4), 859-865.
152. Z Vujaskovic, et al. (2000) Temperature-dependent changes in physiologic parameters of spontaneous canine soft tissue sarcomas after combined radiotherapy and hyperthermia treatment. Int J Radiat Oncol Biol Phys 46(1), 179-185.
153. DM Brizel, et al. (1996) Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Res 56 5347-5350.
154. Z Vujaskovic, et al. (2003) Ultrasound guided pO 2 measurement of breast cancer reoxygenation after neoadjuvant chemotherapy and hyperthermia treatment. Int J Hyperthermia 19(5), 498-506.
155. X Sun, et al. (2008) Changes in tumor hypoxia induced by mild temperature hyperthermia as assessed by dual-tracer immunohistochemistry. Radiother Oncol 88(2), 269-276.
156. JJW Lagendijk (1990) Thermal models: principles and implementation. SB Field, JW Hand,(Eds) An Introduction to the practical aspects of clinical hyperthermia London, New York: Taylor & Francis 478-512.
157. HH Pennes (1948) Analysis of tissue and arterial blood temperatures in the resting human forearm. J Appl Physiol 85(1), 5-34.
158. JJ Lagendijk (2000) Hyperthermia treatment planning. Phys Med Biol 45(5), R61-R76.
159. H Arkin, LX Xu and KR Holmes (1994) Recent developments in modeling heat transfer in blood perfused tissues. IEEE Trans Biomed Eng 41(2), 97-107.
160. M Gautherie (Eds) (1990) Thermal dosimetry and treatment planning. Clinical thermology: subseries thermotherapy Berlin: Springer-Verlag 216.
161. MH Seegenschmiedt, P Fessenden and CC Vernon (1995) Thermoradiotherapy and thermochemotherapy, vol. 1: Biology, Physiology, and Physics. Berlin: Springer-Verlag
162. P Fessenden and JW Hand (1995) Hyperthermia therapy physics. AR Smith,(Eds) Medical radiology: radiation therapy physics Berlin: Springer-Verlag 315-363.
163. TV Samulski, et al. (1990) Clinical experience with a multi-element ultrasonic hyperthermia system: analysis of treatment temperatures. Int J Hyperthermia 6(5), 909-922.
164. K Hynynen (1990) Hot spots created at skin-air interfaces during ultrasound hyperthermia. Int J Hyperthermia 6(6), 1005-1012.
165. SA Goss, RL Johnston and F Dunn (1978) Comprehensive compilation of empirical ultrasonic properties of mammalian tissues. J Acoust Soc Am 64(2), 423-457.
166. SB Field and JW Hand (1990) An introduction to the practical aspects of clinical hyperthermia. London: Taylor & Francis
167. M Gautherie (Eds) (1990) Methods of External hyperthermic heating. Clinical thermology: subseries thermotherapy Berlin: Springer-Verlag 143.
168. PR Stauffer (2000) Thermal therapy techniques for skin and superficial tissue disease. TP Ryan,(Eds) Critical reviews: matching the energy source to the clinical need Bellingham, WA: SPIE Optical Engineering Press 327-367.
169. PR Stauffer (2005) Evolving technology for thermal therapy of cancer. Int J Hyperthermia 21(8), 731-744.
170. CK Chou, et al. (1990) Evaluation of captive bolus applicators. Med Phys 17(4), 705-709.
171. WL Straube, et al. (1990) SAR patterns of external 915 MHz microwave applicators. Int J Hyperthermia 6(3), 665-670.
172. MD Sherar, et al. (1993) Beam shaping for microwave waveguide hyperthermia applicators. Int J Radiat Oncol Biol Phys 25(5), 849-857.
173. Y Nishimura, et al. (1995) Thermoradiotherapy of superficial and subsurface tumours: analysis of thermal parameters and tumour response. Int J Hyperthermia 11(5), 603-613.
174. P Fessenden, et al. (1993) Review of the Stanford experience developing non-focusing scanning and array surface microwave (MW) applicators. EW Gerner, TC Cetas,(Eds) Hyperthermic oncology, 1992 vol. 2 Tucson: Arizona Board of Regents 183-186.
175. Arabe OA, et al: A 400 MHz hyperthermia system using rotating spiral antennas for uniform treatment of large superficial sub-surface tumors. Proceedings of microwave theory and techniques society international microwave symposium, Honolulu, HI, 2007, IEEE Press, pp 1333-1336
176. EL Jones, et al. (2005) Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 23 3079-3085.
177. CJ Diederich and PR Stauffer (1993) Pre-clinical evaluation of a microwave planar array applicator for superficial hyperthermia. Int J Hyperthermia 9(2), 227-246.
178. GC Van Rhoon, PJ Rietveld and J van der Zee (1998) A 433 MHz Lucite cone waveguide applicator for superficial hyperthermia. Int J Hyperthermia 14(1), 13-27.
179. PJM Rietveld, et al. (1998) Quantitative evaluation of 2 × 2 arrays of Lucite cone applicators in flat layered phantoms using Gaussian-beam-predicted and thermographically measured SAR distributions. Phys Med Biol 43(8), 2207-2220.
180. EA Gelvich and VN Mazokhin (2002) Contact flexible microstrip applicators (CFMA) in a range from microwaves up to short waves. IEEE Trans Biomed Eng 49 1015-1023.
181. WM Lee, et al. (2004) Assessment of the performance characteristics of a prototype 12-element capacitive contact flexible microstrip applicator (CFMA-12) for superficial hyperthermia. Int J Hyperthermia 20(6), 607-624.
182. MK Gopal, et al. (1992) Current sheet applicator arrays for superficial hyperthermia of chestwall lesions. Int J Hyperthermia 8(2), 227-240.
183. ER Lee, et al. (1992) Body conformable 915 MHz microstrip array applicators for large surface area hyperthermia. IEEE Trans Biomed Eng 39(5), 470-483.
184. JE Johnson, et al. (2006) Evaluation of a dual-arm Archimedean spiral array for microwave hyperthermia. Int J Hyperthermia 22(6), 475-490.
185. P Stauffer, et al. (2007) Progress on conformal microwave array applicators for heating chestwall disease. T Ryan,(Eds) Proceedings of SPIE San Jose: SPIE Press 1-13.
186. T Juang, et al. (2006) Multilayer conformal applicator for microwave heating and brachytherapy treatment of superficial tissue disease. Int J Hyperthermia 22(7), 527-544.
187. R Taschereau, et al. (2004) Radiation dosimetry of a conformal heat-brachytherapy applicator. Tech Cancer Res Treat 3(4), 347-358.
188. PR Stauffer, CJ Diederich and J Pouliot (2005) Thermal therapy for cancer. B Thomadsen, M Rivard, W Butler,(Eds) Brachytherapy physics ed 2 Madison WI: Medical Physics Publishing Joint AAPM/ABS Summer School, Med Phys Monograph No 31
189. PR Stauffer, et al. (2005) Progress on system for applying simultaneous heat and brachytherapy to large-area surface disease. SPIE BIOS San Jose: SPIE Press
190. K Arunachalam, PF Maccarini and PR Stauffer (2008) A thermal monitoring sheet with low influence from adjacent waterbolus for tissue surface thermometry during clinical hyperthermia. IEEE Trans Biomed Eng 55(10), 2397-2406.
191. PR Stauffer, S Jacobsen and DG Neuman (2001) Microwave array applicators for radiometry controlled superficial hyperthermia. TP Ryan,(Eds) Thermal Treatment of tissue: energy delivery and assessment Bellingham, WA: SPIE Press 19-29.
192. M Chive (1990) Use of microwave radiometry for hyperthermia monitoring and as a basis for thermal dosimetry. M Gautherie,(Eds) Methods of hyperthermia control, Heidelberg Berlin: Springer-Verlag 113-128.
193. S Jacobsen, PR Stauffer and DG Neuman (2000) Dual-mode antenna design for microwave heating and noninvasive thermometry of superficial tissue disease. IEEE Trans Biomed Eng 47(11), 1500-1509.
194. P Novak, et al. (2001) Ultrasonic approach to noninvasive temperature monitoring during microwave thermotherapy. Radioengineering 10(1), 32-37.
195. PM Corry, et al. (1982) Combined ultrasound and radiation therapy treatment of human superficial tumors. Radiology 145(1), 165-169.
196. K Hynynen, et al. (1990) Temperature distributions during clinical scanned, focused ultrasound hyperthermia treatments. Int J Hyperthermia 6(5), 891-908.
197. DP Anhalt, et al. (1993) Scanned ultrasound hyperthermia for treating superficial disease. E Gerner, T Cetas,(Eds) Hyperthermic oncology 1992 vol. 2 Tucson: Arizona Board of Regents 191-192.
198. EG Moros, X Fan and WL Straube (1999) Experimental assessment of power and temperature penetration depth control with a dual frequency ultrasonic system. Med Phys 26(5), 810-817.
199. P Novak, et al. (2005) SURLAS: A new clinical grade ultrasound system for sequential or concomitant thermoradiotherapy of superficial tumors: applicator description. Med Phys 32(1), 230-240.
200. P Novak, et al. (2008) Influence of the SURLAS applicator on radiation dose distributions during simultaneous thermoradiotherapy with helical tomotherapy. Phys Med Biol 53(10), 2509-2522.
201. JA Penagaricano, et al. (2008) Feasibility of concurrent treatment with the scanning ultrasound reflector linear array system (SURLAS) and the helical tomotherapy system. Int J Hyperthermia 24(5), 377-388.
202. K Hynynen, et al. (2001) MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology 219(1), 176-185.
203. N McDannold, et al. (2006) Uterine leiomyomas: MR imaging-based thermometry and thermal dosimetry during focused ultrasound thermal ablation. Radiology 240(1), 263-272.
204. MH Seegenschmiedt and R Sauer (Eds) (1993) Interstitial and intracavitary thermoradiotherapy. Medical Radiology Berlin: Springer-Verlag
205. PR Stauffer, CJ Diederich and MH Seegenschmiedt (1995) Interstitial heating technologies. MH Seegenschmiedt, P Fessenden, CC Vernon,(Eds) Thermoradiotherapy and Thermochemotherapy: Volume 1, Biology, Physiology and Physics Berlin, New York: Springer-Verlag 279-320.
206. MH Seegenschmiedt, et al. (1996) Clinical practice of interstitial thermoradiotherapy. MH Seegenschmiedt, P Fessenden, CC Vernon,(Eds) Thermoradiotherapy and thermochemotherapy: volume 2, clinical applications Berlin, New York: Springer-Verlag 207-320.
207. JW Strohbehn (1987) Interstitial techniques for hyperthermia. SB Field, C Franconi,(Eds) Physics and technology of hyperthermia, Dordrecht Boston, Lancaster: Martinus Nijhoff Publishers 211-240.
208. JC Camart, et al. (1993) 915 MHz microwave interstitial hyperthermia. Part II: array of phase-monitored antennas. Int J Hyperthermia 9(3), 445-454.
209. BS Trembly, et al. (1994) The effect of phase modulation on the temperature distribution of a microwave hyperthermia antenna array in vivo. Int J Hyperthermia 10(5), 691-705.
210. T Satoh, PR Stauffer and JR Fike (1988) Thermal distribution studies of helical coil microwave antennas for interstitial hyperthermia. Int J Radiat Oncol Biol Phys 15(5), 1209-1218.
211. TP Ryan (1991) Comparison of six microwave antennas for hyperthermia treatment of cancer: SAR results for single antennas and arrays. Int J Radiat Oncol Biol Phys 21(2), 403-413.
212. D Haemmerich and FT Lee Jr (2005) Multiple applicator approaches for radiofrequency and microwave ablation. Int J Hyperthermia 21(2), 93-106.
213. JJ Fabre, et al. (1993) 915 MHz microwave interstitial hyperthermia. Part I: Theoretical and experimental aspects with temperature control by multifrequency radiometry. Int J Hyperthermia 9(3), 433-444.
214. JC Camart, et al. (2000) New 434 MHz interstitial hyperthermia system monitored by microwave radiometry: theoretical and experimental results. Int J Hyperthermia 16(2), 95-111.
215. SD Prionas, et al. (1993) Interstitial radiofrequency-induced hyperthermia. EW Gerner, TC Cetas,(Eds) Hyperthermic Oncology 1992 vol. 2 Tucson: Arizona Board of Regents 249-253.
216. Lagendijk JJW, et al: Interstitial hyperthermia & treatment planning: the 27 MHz multi-electrode current source method. Nucletron-Odelft Activity Report No. 6, 1995:83–90.
217. L Handl-Zeller (Eds) (1992) Interstitial hyperthermia Wien, New York: Springer-Verlag
218. AG Visser, et al. (1989) An interstitial hyperthermia system at 27 MHz. Int J Hyperthermia 5(2), 265-276.
219. C Marchal, et al. (1989) Practical interstitial method of heating operating at 27.12 MHz. Int J Hyperthermia 5(4), 451-466.
220. JA DeFord, et al. (1991) Effective estimation and computer control of minimum tumour temperature during conductive interstitial hyperthermia. Int J Hyperthermia 7(3), 441-453.
221. PR Stauffer, TC Cetas and RC Jones (1984) Magnetic induction heating of ferromagnetic implants for inducing localized hyperthermia in deep seated tumors. IEEE Trans Biomed Eng 31 235-251.
222. IA Brezovich, WJ Atkinson and DP Chakraborty (1984) Temperature distributions in tumor models heated by self-regulating nickel-copper alloy thermoseeds. Med Phys 11 145-152.
223. PR Stauffer, et al. (1994) Practical induction heating coil designs for clinical hyperthermia with ferromagnetic implants. IEEE Trans Biomed Eng 41(1), 17-28.
224. TC Cetas, EJ Gross and Y Contractor (1998) A ferrite core/metallic sheath thermoseed for interstitial thermal therapies. IEEE Trans Biomed Eng 45(1), 68-77.
225. H Matsuki, et al. (1987) High quality soft heating method utilizing temperature dependence of permeability and core loss of low curie temperature ferrite. IEEE Trans Magn 23 2440-2442.
226. A Jordan and K Maier-Hauff (2007) Magnetic nanoparticles for intracranial thermotherapy. J Nanosci Nanotechnol 7(12), 4604-4606.
227. P Wust, et al. (2006) Magnetic nanoparticles for interstitial thermotherapy—feasibility, tolerance and achieved temperatures. Int J Hyperthermia 22(8), 673-685.
228. PR Stauffer, et al. (1984) Observations on the use of ferromagnetic implants for inducing hyperthermia. IEEE Trans Biomed Eng 31(1), 76-90.
229. V Master, K Shinohara and P Carroll (2004) Ferromagnetic thermal ablation of locally recurrent prostate cancer: prostate specific antigen results and immediate/intermediate morbidities. J Urelogy 172 2197-2202.
230. B Thiesen and A Jordan (2008) Clinical applications of magnetic nanoparticles for hyperthermia. Int J Hyperthermia 24(6), 467-474.
231. CJ Diederich (1996) Ultrasound applicators with integrated catheter-cooling for interstitial hyperthermia: Theory and preliminary experiments. Int J Hyperthermia 12(2), 279-297.
232. CJ Diederich, et al. (1996) Direct-coupled interstitial ultrasound applicators for simultaneous thermobrachytherapy: A feasibility study. Int J Hyperthermia 12(3), 401-419.
233. AM Kinsey, et al. (2008) Transurethral ultrasound applicators with dynamic multi-sector control for prostate thermal therapy: In vivo evaluation under MR guidance. Med Phys 35(5), 2081-2093.
234. J Chen, et al. (2008) Monitoring prostate thermal therapy with diffusion-weighted MRI. Magn Reson Med 59(6), 1365-1372.
235. CJ Diederich (2005) Thermal ablation and high-temperature thermal therapy: overview of technology and clinical implementation. Int J Hyperthermia 21(8), 745-753.
236. DJ Li (1990) Present status on treatment of esophageal cancer in China. Int J Radiat Oncol Biol Phys 18(2), 477-484.
237. B Sorbe, DI Roos and LG Karlsson (1990) The use of microwave-induced hyperthermia in conjunction with afterloading irradiation of vaginal carcinoma. A preliminary report. Acta Oncol 29(8), 1029-1033.
238. RL Liu, et al. (1991) Heating pattern of helical microwave intracavitary oesophageal applicator. Int J Hyperthermia 7(4), 577-586.
239. H Fosmire, et al. (1993) Feasibility and toxicity of transrectal ultrasound hyperthermia in the treatment of locally advanced adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 26(2), 253-259.
240. NB Smith, MT Buchanan and K Hynynen (1999) Transrectal ultrasound applicator for prostate heating monitored using MRI thermometry. Int J Radiat Oncol Biol Phys 43(1), 217-225.
241. MD Hurwitz, et al. (2005) Hyperthermia combined with radiation in treatment of locally advanced prostate cancer is associated with a favourable toxicity profile. Int J Hyperthermia 21(7), 649-656.
242. R Paglione, et al. (1981) 27 MHz ridged waveguide applicators for localized hyperthermia treatment of deep-seated malignant tumors. Microw J 24(2), 71-80.
243. MK Croghan, et al. (1993) A phase I study of the toxicity of regional hyperthermia with systemic warming. Am J Clin Oncol 16(4), 354-358.
244. AA De Leeuw, et al. (2003) Increasing the systemic temperature during regional hyperthermia: Effect of a cooling strategy on tumour temperatures and side-effects. Int J Hyperthermia 19(6), 655-663.
245. M Van Vulpen, et al. (2003) Comparison of intra-luminal versus intra-tumoural temperature measurements in patients with locally advanced prostate cancer treated with the coaxial TEM system: report of a feasibility study. Int J Hyperthermia 19(5), 481-497.
246. M Kikuchi, et al. (1993) Guide to the use of hyperthermic equipment. 1. Capacitively-coupled heating. Int J Hyperthermia 9(2), 187-203.
247. E Mochiki, et al. (2007) Feasibility study of postoperative intraperitoneal hyperthermochemotherapy by radiofrequency capacitive heating system for advanced gastric cancer with peritoneal seeding. Int J Hyperthermia 23(6), 493-500.
248. GC van Rhoon, et al. (1992) Radiofrequency capacitive heating of deep-seated tumours using pre-cooling of the subcutaneous tissues: results on thermometry in Dutch patients. Int J Hyperthermia 8(6), 843-854.
249. PF Turner (1984) Regional hyperthermia with an annular phased array. IEEE Trans Biomed Eng 31(1), 106-114.
250. D Fatehi and GC van Rhoon (2008) SAR characteristics of the Sigma-60-Ellipse applicator. Int J Hyperthermia 24(4), 347-356.
251. GC Van Rhoon, et al. (2003) Characterization of the SAR-distribution of the Sigma-60 applicator for regional hyperthermia using a Schottky diode sheet. Int J Hyperthermia 19(6), 642-654.
252. M Albregts, et al. (2004) A feasibility study in oesophageal carcinoma using deep loco-regional hyperthermia combined with concurrent chemotherapy followed by surgery. Int J Hyperthermia 20(6), 647-659.
253. J Gellermann, et al. (2000) Clinical evaluation and verification of the hyperthermia treatment planning system hyperplan. Int J Radiat Oncol Biol Phys 47(4), 1145-1156.
254. HP Kok, et al. (2006) Prospective treatment planning to improve locoregional hyperthermia for oesophageal cancer. Int J Hyperthermia 22(5), 375-389.
255. P Wust, et al. (2000) Electric field distributions in a phased-array applicator with 12 channels: measurements and numerical simulations. Med Phys 27(11), 2565-2579.
256. D Carter, et al. (1998) Magnetic resonance thermometry during hyperthermia for human high-grade sarcoma. Int J Radiat Oncol Biol Phys 40(4), 815-822.
257. J Gellermann, et al. (2006) Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry. Cancer 107(6), 1373-1382.
258. Z Li, et al. (2008) Towards the validation of a commercial hyperthermia treatment planning system (invited paper). Microw J 51(12), 28-42.
259. Li Z, et al: Determining SAR/temperature distribution within an annular phased array using proton resonance frequency shift imaging with magnetic resonance imaging, Int J Hyperthermia (in press).
260. P Stauffer, et al. (2009) Clinical utility of magnetic resonance thermal imaging (MRTI) for realtime guidance of deep hyperthermia in SPIE. San Jose: SPIE Press
261. Stakhursky V, et al: Real-time MRI guided hyperthermia treatment using a fast adaptive algorithm, Phys Med Biol (in press).
262. K Hynynen, et al. (2001) MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: A feasibility study. Radiology 219(1), 176-185.
263. FA Jolesz, et al. (2005) MR imaging-controlled focused ultrasound ablation: a noninvasive image-guided surgery. Magn Reson Imaging Clin N Am 13(3), 545-560.
264. RT Pettigrew, et al. (1974) Clinical effects of whole-body hyperthermia in advanced malignancy. Br Med J 4(5946), 679-682.
265. H Gerad, et al. (1984) Doxorubicin, cyclophosphamide and whole body hyperthermia for treatment of advanced soft tissue sarcoma. Cancer 53(12), 2585-2591.
266. JM Bull, et al. (2008) The importance of schedule in whole body thermochemotherapy. Int J Hyperthermia 24(2), 171-181.
267. E Repasky and R Issels (2002) Physiological consequences of hyperthermia: heat, heat shock proteins and the immune response. Int J Hyperthermia 18(6), 486-489.
268. M Gautherie (Eds) (1990) Methods of hyperthermia control. Clinical thermology: subseries thermotherapy Berlin: Springer-Verlag
269. RG Dickinson (1985) Thermal conduction errors of manganin-constantan thermocouple arrays. Phys Med Biol 30 445-453.
270. D Anhalt and K Hynynen (1992) Thermocouples—the Arizona experience with in-house manufactured probes. Med Phys 19(5), 1325-1333.
271. LL Hoh and FM Waterman (1995) Use of manganin-constantan thermocouples in thermometry units designed for copper-constantan thermocouples. Int J Hyperthermia 11(1), 131-138.
272. KW Chan and CK Chou (1993) Use of thermocouples in the intense fields of ferromagnetic implant hyperthermia. Int J Hyperthermia 9(6), 831-848.
273. KW Chan, et al. (1988) Perturbations due to the use of catheters with non-perturbing probes. Int J Hyperthermia 4 699-702.
274. PK Sneed, et al. (1998) Survival benefit of hyperthermia in a prospective, randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 40(2), 287-295.
275. P Tarczy-Hornoch, et al. (1992) Automated mechanical thermometry probe mapping systems for hyperthermia. Int J Hyperthermia 8(4), 543-554.
276. MW Dewhirst, et al. (1990) RTOG quality assurance guidelines for clinical trials using hyperthermia. Int J Radiat Oncol Biol PHys 18(5), 1249-1259.
277. B Emami, et al. (1991) RTOG quality assurance guidelines for interstitial hyperthermia. Int J Radiat Oncol Biol Phys 20(5), 1117-1124.
278. FM Waterman and LL Hoh (1995) A recommended revision in the RTOG thermometry guidelines for hyperthermia administered by ultrasound. Int J Hyperthermia 11(1), 121-130.
279. MD Sapozink, et al. (1991) RTOG quality assurance guidelines for clinical trials using hyperthermia for deep-seated malignancy. Int J Radiat Oncol Biol Phys 20(5), 1109-1115.
280. CJ Schneider, et al. (1994) Quality assurance in various radiative hyperthermia systems applying a phantom with LED matrix. Int J Hyperthermia 10(5), 733-747.
281. A Tennant, J Conway and AP Anderson (1990) A robot-controlled microwave antenna system for uniform hyperthermia treatment of superficial tumours with arbitrary shape. Int J Hyperthermia 6(1), 193-202.
282. K Arunachalam, et al. (2008) Performance evaluation of a conformal thermal monitoring sheet sensor array for measurement of surface temperature distributions during superficial hyperthermia treatments. Int J Hyperthermia 24(4), 313-325.
283. KD Paulsen, et al. (1996) Initial in vivo experience with EIT as a thermal estimator during hyperthermia. Int J Hyperthermia 12(5), 573-591.
284. PM Meaney, et al. (2003) Microwave thermal imaging: Initial in vivo experience with a single heating zone. Int J Hyperthermia 19(6), 617-641.
285. L Dubois, et al. (1996) Temperature control and thermal dosimetry by microwave radiometry in hyperthermia. IEEE Trans Microw Theory Tech 44 1755-1761.
286. K Arunachalam, et al. (2008) Characterization of a digital microwave radiometry system for noninvasive thermometry using a temperature-controlled homogeneous test load. Phys Med Biol 53(14), 3883-3901.
287. N McDannold, et al. (2008) Evaluation of referenceless thermometry in MRI-guided focused ultrasound surgery of uterine fibroids. J Magn Reson Imaging 28(4), 1026-1032.
288. J Gellermann, et al. (2005) A practical approach to thermography in a hyperthermia/magnetic resonance hybrid system: validation in a heterogeneous phantom. Int J Radiat Oncol Biol Phys 61(1), 267-277.
289. KS Cheng, et al. (2008) Fast temperature optimization of multi-source hyperthermia applicators with reduced-order modeling of ‘virtual sources’. Phys Med Biol 53(6), 1619-1635.
290. M Weihrauch, et al. (2007) Adaptation of antenna profiles for control of MR guided hyperthermia (HT) in a hybrid MR-HT system. Med Phys 34(12), 4717-4725.
291. JL Meyer, et al. (1989) Hyperthermic oncology: current biology, physics and clinical results. Pharmac Ther 42 251-288.
292. CA Perez and B Emami (1989) Clinical trials with local (external and interstitial) irradiation and hyperthermia. Radiol Clin N Am 27(3), 525-542.
293. CA Perez, et al. (1991) Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors. Final report by the Radiation Therapy Oncology Group. Am J Clin Oncol 14(2), 133-141.
294. PN Shrivastava, et al. (1988) Hyperthermia thermometry evaluation: Criteria and guidelines. Int J Radiat Oncol Biol Phys 14 327-335.
295. R Valdagni, DS Kapp and C Valdagni (1986) N3 (TNM-UICC) metastatic neck nodes managed by combined radiation therapy and hyperthermia: Clinical results and analysis of treatment parameters. Int J Hyperthermia 2(2), 189-200.
296. CA Perez, et al. (1989) Quality assurance problems in clinical hyperthermia and their impact on therapeutic outcome: a report by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 16 551-558.
297. RJ Myerson, et al. (1990) Tumor control in long-term survivors following superficial hyperthermia. Int J Radiat Oncol Biol Phys 18(5), 1123-1129.
298. RJ Myerson, et al. (1992) Equilibrium temperature distributions in uniform phantoms for superficial microwave applicators: implications for temperature-based standards of applicator adequacy. Int J Hyperthermia 8(1), 11-21.
299. JR Oleson, et al. (1989) Tumor temperature distributions predict hyperthermia effect. Int J Radiat Oncol Biol Phys 16 559-570.
300. DS Kapp, et al. (1992) Parameters predictive for complications of treatment with combined hyperthermia and radiation therapy. Int J Radiat Oncol Biol Phys 22 998-1008.
301. WC Dewey (1994) Arrhenius relationships from the molecule and cell to the clinic. Int J Hyperthermia 10(4), 457-483.
302. RJ Myerson, et al. (1999) Simultaneous superficial hyperthermia and external radiotherapy: report of thermal dosimetry and tolerance to treatment. Int J Hyperthermia 15(4), 251-266.
303. M Xu, et al. (2002) Radiosensitization of heat resistant human tumour cells by 1 hour at 41.1 degrees C and its effect on DNA repair. Int J Hyperthermia 18(5), 385-403.
304. MR Horsman and J Overgaard (1997) Can mild hyperthermia improve tumour oxygenation? Int J Hyperthermia 13(2), 141-147.
305. K Iwata, et al. (1996) Tumour pO 2 can be increased markedly by mild hyperthermia. Br J Cancer 27(Suppl), S217-S221.
306. RJ Myerson, et al. (2006) Monitoring the effect of mild hyperthermia on tumour hypoxia by Cu-ATSM PET scanning. Int J Hyperthermia 22(2), 93-115.
307. DS Kapp, et al. (1990) Two or six hyperthermia treatments as an adjunct to radiation therapy yield similar tumor responses: results of a randomized trial. Int J Radiat Oncol Biol Phys 19(6), 1481-1495.
308. B Emami, et al. (1992) Combined hyperthermia and irradiation in the treatment of superficial tumors: Results of a prospective randomized trial of hyperthermia fractionation (1/wk vs 2/wk). Int J Radiat Oncol Biol Phys 24(1), 145-152.
309. KA Leopold, et al. (1989) Preoperative hyperthermia and radiation for soft tissue sarcomas: Advantage of two vs. one hyperthermia treatments per week. Int J Radiat Oncol Biol Phys 16 107-115.
310. G Arcangeli, et al. (1991) One versus four heat treatments in combination with radiotherapy in metastatic mammary carcinoma. Int J Radiat Oncol Biol Phys 21(6), 1569-1574.
311. EL Jones, et al. (2005) A randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 23 3079-3085.
312. RJ Myerson, et al. (2004) Modelling heat-induced radiosensitization: clinical implications. Int J Hyperthermia 20(2), 201-212.
313. JR Oleson, et al. (1989) Tumor temperature distributions predict hyperthermia effect. Int J Radiat Oncol Biol Phys 16 559-570.
314. J Overgaard (1982) The design of clinical trials. SB Field, C Franconi,(Eds) Hyperthermic oncology: physics and technology of hyperthermia Amsterdam: Martinus Nijhoff Publishers
315. G Arcangeli, et al. (1984) Problem of sequence and fractionation in the clinical application of combined heat and radiation. Cancer Res 44(Suppl 10), 4857s-4863s.
316. P Bey, et al. (1984) Potentialisation de la radiothérapie par hyperthermie locale. A propos de 90 tumeurs superficielles comparables (abstract). Bull Cancer 71 263.
317. PRC Dunlop, et al. (1986) An assessment of local hyperthermia in clinical practice. Int J Hyperthermia 2(1), 39-50.
318. M Hiraoka, et al. (1984) Clinical results of radiofrequency hyperthermia combined with radiation in the treatment of radioresistant cancers. Cancer 54(12), 2898-2904.
319. GCW Howard, et al. (1987) Hyperthermia and radiation in the treatment of superficial malignancy: an analysis of treatment parameters, response and toxicity. Int J Hyperthermia 3(1), 1-8.
320. L. RY Li, et al. (1984) Effect of hyperthermia combined with radiation in the treatment of superficial malignant lesion in 90 patients. J Overgaard,(Eds) Hyperthermic oncology 1984 vol. 1 London: Taylor & Francis 395-397.
321. CE Lindholm, et al. (1987) Microwave-induced hyperthermia and radiotherapy in human superficial tumours: Clinical results with a comparative study of combined treatment versus radiotherapy alone. Int J Hyperthermia 3(5), 393-411.
322. RS Scott, et al. (1984) Local hyperthermia in combination with definitive radiotherapy: increased tumor clearance, reduced recurrence rate in extended follow-up. Int J Radiat Oncol Biol Phys 10(11), 2119-2123.
323. RA Steeves, et al. (1986) Matched-pair analysis of response to local hyperthermia and megavoltage electron therapy for superficial human tumors. Endocurietherapy/Hyperthermia Oncol 2(4), 163-170.
324. GC Li and GM Hahn (1980) A proposed operational model of thermotolerance based on effects of nutrients and the initial treatment temperature. Cancer Res 40 4501-4508.
325. G Arcangeli, et al. (1985) Tumor response to heat and radiation: prognostic variables in the treatment of neck node metastases from head and neck cancer. Int J Hyperthermia 1(3), 207-217.
326. D González González, JD van Dijk and LE Blank (1988) Chestwall recurrences of breast cancer: results of combined treatment with radiation and hyperthermia. Radiother Oncol 12(2), 95-103.
327. E Kjellén, CE Lindholm and P Nilsson (1989) Radiotherapy in combination with hyperthermia in recurrent or metastatic mammary carcinomas. T Sugahara, M Saito,(Eds) Hyperthermic oncology 1988 vol. 2 London: Taylor & Francis 426-429.
328. J Van der Zee, et al. (1984) Thermal enhancement of radiotherapy in breast carcinoma. J Overgaard,(Eds) Hyperthermic Oncology 1984 vol. 1 London: Taylor & Francis 345-348.
329. G Arcangeli, et al. (1987) Radiotherapy and hyperthermia: analysis of clinical results and identification of prognostic variables. Cancer 60(5), 950-956.
330. D González González, et al. (1986) Combined treatment with radiation and hyperthermia in metastatic malignant melanoma. Radiother Oncol 6 105-113.
331. JH Kim, EW Hahn and SA Ahmed (1982) Combination hyperthermia and radiation therapy for malignant melanoma. Cancer 50(3), 478-482.
332. J Overgaard and M Overgaard (1987) Hyperthermia as an adjuvant to radiotherapy in the treatment of malignant melanoma. Int J Hyperthermia 3(6), 483-501.
333. DS Kapp, et al. (1988) Stanford University institutional report. Phase I evaluation of equipment for hyperthermia treatment of cancer. Int J Hyperthermia 4(1), 75-115.
334. MW Dewhirst, et al. (1990) RTOG quality assurance guidelines for clinical trials using hyperthermia. Int J Radiat Oncol Biol Phys 18(5), 1249-1259.
335. S Egawa, et al. (1989) A randomized clinical trial of hyperthermia and radiation versus radiation alone for superficially located cancers. J Jpn Soc Ther Radiol Oncol 1 135-140.
336. J Overgaard, et al. (1995) Thermoradiotherapy of malignant tumors. European randomized multicenter trials evaluating the effect of adjuvant hyperthermia in radiotherapy. HD Kogelnik,(Eds) Progress in Radio-Oncology V Bologna: Monduzzi Editore 507-513.
337. M Sherar, et al. (1997) Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial. Int J Radiat Oncol Biol Phys 39(2), 371-380.
338. JW Hand, et al. (1997) Analysis of thermal parameters obtained during phase III trials of hyperthermia as an adjunct to radiotherapy in the treatment of breast carcinoma. Int J Hyperthermia 13(4), 343-364.
339. J Overgaard, et al. (1995) Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet 345 540-543.
340. B Emami and CA Perez (1987) Combination of surgery, irradiation, and hyperthermia in treatment of recurrences of malignant tumors. Int J Radiat Oncol Biol Phys 13(4), 611-613.
341. DS Kapp, et al. (1992) Thermoradiotherapy for residual microscopic cancer: elective or post-excisional hyperthermia and radiation therapy in the management of local-regional recurrent breast cancer [see comments]. Int J Radiat Oncol Biol Phys 24(2), 261-277.
342. PK Sneed (1995) Clinical interstitial hyperthermia: where have we been? Where are we going? U Hagen, et al., (Eds) Radiation Research 1895–1995 vol. 2 Würzburg: 10th ICRR Society 1009-1012.
343. MH Seegenschmiedt, LW Brady and R Sauer (1990) Interstitial thermoradiotherapy: review on technical and clinical aspects. Am J Clin Oncol 13(4), 352-363.
344. MH Seegenschmiedt, et al. (1995) Thermoradiotherapy for malignant brain tumors: review of biological and clinical studies. Endocurietherapy/Hyperthermia Oncol 11(4), 201-221.
345. PK Sneed, et al. (1992) Thermoradiotherapy of recurrent malignant brain tumors. Int J Radiat Oncol Biol Phys 23(4), 853-861.
346. PK Sneed, DA Larson and PH Gutin (1994) Brachytherapy and hyperthermia for malignant astrocytoma. Semin Oncol 21(2), 186-197.
347. B Stea, et al. (1994) Interstitial irradiation versus interstitial thermoradiotherapy for supratentorial malignant gliomas: a comparative survival analysis. Int J Radiat Oncol Biol Phys 30(3), 591-600.
348. EG Moros, et al. (1995) Simultaneous delivery of electron beam therapy and ultrasound hyperthermia utilizing scanning reflectors: a feasibility study. Int J Radiat Oncol Biol Phys 31(4), 893-904.
349. EP Armour, et al. (1994) Hyperthermic enhancement of high dose-rate irradiation in 9L gliosarcoma cells. Int J Radiat Oncol Biol Phys 28(1), 171-177.
350. HJ Feldmann, et al. (1993) Deep regional hyperthermia: comparison between the annular phased array and the Sigma-60 applicator in the same patients. Int J Radiat Oncol Biol Phys 26(1), 111-116.
351. HJ Feldmann, et al. (1993) Thermoradiotherapy in locally advanced deep seated tumours—thermal parameters and treatment results. Radiother Oncol 26(1), 38-44.
352. W Tilly, et al. (2001) Temperature data and specific absorption rates in pelvic tumours: predictive factors and correlations. Int J Hyperthermia 17(2), 172-188.
353. D Fatehi, et al. (2007) RF-power and temperature data analysis of 444 patients with primary cervical cancer: Deep hyperthermia using the Sigma-60 applicator is reproducible. Int J Hyperthermia 23(8), 623-643.
354. Z Petrovich, et al. (1989) Regional hyperthermia for advanced tumors: a clinical study of 353 patients. Int J Radiat Oncol Biol Phys 16(3), 601-607.
355. RJ Myerson, et al. (1996) A phase I/II study to evaluate radiation therapy and hyperthermia for deep-seated tumours: a report of RTOG 89–08. Int J Hyperthermia 12(4), 449-459.
356. K Karasawa, et al. (1994) Thermoradiotherapy in the treatment of locally advanced nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 30(5), 1171-1177.
357. M Hiraoka, et al. (1992) Regional hyperthermia combined with radiotherapy in the treatment of lung cancers. Int J Radiat Oncol Biol Phys 22(5), 1009-1014.
358. DM Sullivan, R Ben-Yosef and DS Kapp (1993) Stanford 3-D hyperthermia treatment planning system. Int J Hyperthermia 9(5), 627-643.
359. JJW Lagendijk, et al. (1998) ESHO quality assurance guidelines for regional hyperthermia. Int J Hyperthermia 14(2), 125-133.
360. MD Sapozink, et al. (1991) RTOG quality assurance guidelines for clinical trials using hyperthermia for deep-seated malignancy. Int J Radiat Oncol Biol Phys 20 1109-1115.
361. J Van der Zee and D González González (2002) The Dutch Deep Hyperthermia Trial: results in cervical cancer. Int J Hyperthermia 18(1), 1-12.
362. Y Harima, et al. (2001) A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical cancer. Int J Hyperthermia 17(2), 97-105.
363. A Vasanthan, et al. (2005) Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency.[see comment]. Int J Radiat Oncol Biol Phys 61(1), 145-153.
364. HI Robins, AJ Neville and JD Cohen (1992) Whole Body Hyperthermia: biological, physical and clinical aspects. Berlin: Springer-Verlag
365. WG Kraybill, et al. (2002) A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: Correlation with mouse models. Int J Hyperthermia 18(3), 253-266.
366. JR Ostberg and EA Repasky (2006) Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function. Cancer Immunol Immunother 55(3), 292-298.
367. CC Vernon, et al. (1996) Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. Int J Radiat Oncol Biol Phys 35(4), 731-744.
368. J Overgaard, et al. (1995) Thermoradiotherapy of malignant tumors. European randomized multicenter trials evaluating the effect of adjuvant hyperthermia in radiotherapy. HD Kogelnik,(Eds) Progress in radio-oncology V Bologna: Monduzzi Editore 507-513.
369. J Van der Zee, et al. (2000) Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Lancet 355 1119-1125.
370. S Sharma, et al. (1991) Local thermo-radiotherapy in carcinoma cervix: improved local control versus increased incidence of distant metastases. Asia Oceania J Obstet Gynaecol 17(1), 5-12.
371. BA Berdov and GZ Menteshashvili (1990) Thermoradiotherapy of patients with locally advanced carcinoma of the rectum. Int J Hyperthermia 6(5), 881-890.
372. Overgaard J: Personal communication. 1995.
373. MH Falk and RD Issels (2001) Hyperthermia in oncology. Int J Hyperthermia 17(1), 1-18.
374. JMC Bull, et al. (1992) Chemotherapy resistant sarcoma treated with whole body hyperthermia (WBH) combined with 1-3-Bis(2-chloroethyl)-1-nitrosourea (BCNU). Int J Hyperthermia 8(3), 297-304.
375. R Engelhardt, et al. (1982) Preliminary results in the treatment of oat cell carcinoma of the lung by combined application of chemotherapy (CT) and whole-body hyperthermia. Prog Clin Biol Res 107 761-765.
376. R Engelhardt, et al. (1990) Treatment of disseminated malignant melanoma with cisplatin in combination with whole-body hyperthermia and doxorubicin. Int J Hyperthermia 6(3), 511-515.
377. KA Leopold, et al. (1993) Intraperitoneal cisplatin and regional hyperthermia for ovarian carcinoma. Int J Radiat Oncol Biol Phys 27(5), 1245-1251.
378. AM Westermann, et al. (2001) A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer. Eur J Cancer 37(9), 1111-1117.
379. K Sugimachi, et al. (1994) Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: a prospective randomized trial. Int J Hyperthermia 10(4), 485-493.
380. RD Issels and M Schlemmer (2002) Current trials and new aspects in soft tissue sarcoma of adults. Cancer Chemother Pharmacol 49(Suppl 1), S4-S8.
381. F Ghussen, et al. (1989) Hyperthermic perfusion with chemotherapy for melanoma of the extremities. World J Surg 13(5), 598-602.
382. HS Koops, et al. (1998) Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. J Clin Oncol 16(9), 2906-2912.
383. JW Park (2002) Liposome-based drug delivery in breast cancer treatment. Breast Cancer Res 4(3), 95-99.
384. Park JW, et al: Hyperthermia + doxil significantly enhances drug delivery and efficacy in metastatic breast cancer of the chest wall: A phase I/II study. In proceedings of the 37 th annual meeting of American Society of Clinical Oncology, San Francisco, 2001.
385. Park JW, et al: Hyperthermia significantly enhances drug delivery and efficacy of pegylated liposomal doxorubicin in metastatic breast cancer of the chest wall: A phase I/II study. Paper presented at the forty-ninth annual meeting of the Radiation Research Society and the twentieth annual meeting of the North American Hyperthermia Society. Reno, Nevada, 2002.
386. Bull JMC, et al: A phase I-II clinical trial of fever-range whole-body hyperthermia combined with liposomal doxorubicin (Doxil), 5-fluorouracil (5-FU), & metronomic interferon-a (IFN-a): an interim report. Paper presented at the forty-ninth annual meeting of the Radiation Research Society and the twentieth annual meeting of the North American Hyperthermia Society. Reno, Nevada, 2002.
387. K Kitamura, et al. (1995) Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma. J Surg Oncol 60(1), 55-58.
388. VE Kouloulias, et al. (2002) Liposomal doxorubicin in conjunction with reirradiation and local hyperthermia treatment in recurrent breast cancer: a phase I/II trial. Clin Cancer Res 8(2), 374-382.
389. R Colombo, et al. (2003) Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma [see comment]. J Clin Oncol 21(23), 4270-4276.
390. S Janetzki, et al. (2000) Immunization of cancer patients with autologous cancer-derived heat shock protein gp96: A pilot study. Int J Cancer 88(2), 232-238.
391. Amato RJ, et al: Active specific immunotherapy in patients with renal cell carcinoma (RCC) using autologous tumor derived heat shock protein-peptide complex-96 (HSPPC-96) vaccine (abstract). Paper presented at the thirty-fifth annual meeting of the American Society of Clinical Oncology, Atlanta, Georgia, 1999.
392. Eton O, et al: Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients (PTS) with metastatic melanoma, 2000, in American Association of Cancer Research.
393. MM Caudill and Z Li (2001) HSPPC-96: A personalised cancer vaccine. Expert Opin Biol Ther 1(3), 539-547.
394. MH Manjili, et al. (2002) Immunotherapy of cancer using heat shock proteins. Front Biosci 7 d43-d52.
395. PK Srivastava, et al. (1998) Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. Immunity 8(6), 657-665.
396. NE Blachere and PK Srivastava (1995) Heat shock protein-based cancer vaccines and related thoughts on immunogenicity of human tumors. Semin Cancer Biol 6(6), 349-355.
397. CV Nicchitta (1998) Biochemical, cell biological and immunological issues surrounding the endoplasmic reticulum chaperone GRP94/gp96. Curr Opin Immunol 10(1), 103-109.
398. D Przepiorka and PK Srivastava (1998) Heat shock protein-peptide complexes as immunotherapy for human cancer. Mol Med Today 4(11), 478-484.
399. S Basu and PK Srivastava (2000) Heat shock proteins: the fountainhead of innate and adaptive immune responses. Cell Stress Chaperones 5(5), 443-451.
400. DL Denman, et al. (1991) Therapeutic responses of spontaneous canine malignancies to combinations of radiotherapy and hyperthermia. Int J Radiat Oncol Biol Phys 21(2), 415-422.
401. EL Gillette, et al. (1987) Response of canine oral carcinomas to heat and radiation. Int J Radiat Oncol Biol Phys 13(12), 1861-1867.
402. SM Gillette, et al. (1992) Response of canine soft tissue sarcomas to radiation or radiation plus hyperthermia: a randomized phase II study. Int J Hyperthermia 8(3), 309-320.
403. D Frew, et al. (1995) Response of cannice soft tissue sarcomas to radiation or radiation plus hyperthermia: results of a randomized phase III clinical study. Int J Hyperthermia 11 217.
404. DE Thrall, et al. (1999) Use of whole body hyperthermia as a method to heat inaccessible tumours uniformly: a phase III trial in canine brain masses. Int J Hyperthermia 15(5), 383-398.
405. DE Thrall, et al. (1996) Radiation plus local hyperthermia versus radiation plus the combination of local and whole-body hyperthermia in canine sarcomas. Int J Radiat Oncol Biol Phys 34(5), 1087-1096.
406. CA Novotney, et al. (1992) Phase I evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma. J Vet Intern Med 6(4), 245-249.
407. RL Page, et al. (1992) Phase III evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma. Int J Hyperthermia 8(2), 187-197.
408. JR Oleson (1995) Hyperthermia from the clinic to the laboratory: a hypothesis. Int J Hyperthermia 11(3), 315-322.
409. U Raymond, et al. (1980) Microwave-induced local hyperthermia in combination with radiotherapy of human malignant tumors. Cancer 45(4), 638-646.
410. D González González, JDP van Dijk and LECM Blank (1988) Chestwall recurrences of breast cancer: results of combined treatment with radiation and hyperthermia. Radiother Oncol 12(2), 95-103.
411. D González González, et al. (1986) Combined treatment with radiation and hyperthermia in metastatic malignant melanoma. Radiother Oncol 6(2), 105-113.